Liver transplantation across ABO blood groups

Area of Science:

• Immunology
• Transplantation Medicine
• Hematology

Background:

• Liver transplantation is a life-saving procedure for end-stage liver disease.
• Donor-recipient ABO blood group compatibility is a critical factor in organ transplant success.
• Understanding the impact of ABO mismatches on liver allograft survival is essential for optimizing transplant outcomes.

Purpose of the Study:

• To investigate the effect of donor-recipient ABO blood group mismatches on orthotopic liver allograft survival.
• To identify specific patient populations or graft types where ABO incompatibility may be less detrimental or even acceptable.

Main Methods:

• Retrospective review of 671 first, second, and third orthotopic liver allografts in 520 patients.
• Analysis of graft survival rates in relation to donor-recipient ABO blood group identity and incompatibility.
• Stratification of data by patient age and graft number (first, second, third).

Main Results:

• A significant survival advantage was observed for ABO-identical donor-recipient pairs.
• This advantage was particularly pronounced in adult recipients and for first-time liver transplants.
• A substantial proportion of ABO-incompatible liver allografts demonstrated successful survival, defying initial expectations.

Conclusions:

• ABO identity is a crucial factor for successful liver allograft survival, especially in adults and for primary transplants.
• ABO-incompatible grafts can be considered in specific scenarios, such as pediatric recipients with limited donor availability or patients with urgent transplantation/retransplantation needs.
• Careful patient selection and consideration of urgency are vital when utilizing ABO-incompatible liver allografts.